(Q40859536)

24 September 2017

title

Why do we not have an HIV vaccine and how can we make one? . (English)

1 reference

24 September 2017

Burton DR

1

1 reference

24 September 2017

Moore JP

series ordinal

2

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 May 1998

1 reference

24 September 2017

1 reference

24 September 2017

volume

4

1 reference

24 September 2017

issue

5 Suppl

1 reference

24 September 2017

page(s)

495-498

1 reference

A vaccine for HIV type 1: the antibody perspective

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-495

Immune responses in HIV-exposed seronegatives: have they repelled the virus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-495

Immunity to retroviral infection: the Friend virus model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-495

A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-495

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-495

Strategies for AIDS vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-495

Macaques infected with attenuated simian immunodeficiency virus resist superinfection with virulence-revertant virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-495

HIV vaccines: where we are and where we are going

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-495

The highest attainable standard: ethical issues in AIDS vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-495

Host immunobiology and vaccine development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-495

Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-495

7 January 2021

HIV-1-specific cytotoxic T lymphocytes and the control of HIV-1 replication

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-495

7 January 2021

HIV versus cytotoxic T lymphocytes--the war being lost

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-495

7 January 2021

Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-495

7 January 2021

Live, attenuated simian immunodeficiency virus vaccines elicit potent resistance against a challenge with a human immunodeficiency virus type 1 chimeric virus.

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-495

7 January 2021

Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-495

7 January 2021

Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection Group

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-495

7 January 2021

Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type 1 envelope with a combination vaccine regimen. AIDS Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-495

7 January 2021

Genetic and immunologic characterization of viruses infecting MN-rgp120-vaccinated volunteers

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-495

7 January 2021

Identifiers

DOI

10.1038/NM0598SUPP-495

1 reference

24 September 2017

1 reference